- Emerging Role of Dual Glucagon-Like Peptide-1 (GLP-1)/Glucose-Dependent Insulinotropic Polypeptide (GIP) Receptor Agonists in Cardiovascular Prevention Cureus
- GLP-1 drugs combined with healthy lifestyle habits linked with reduced cardiovascular risk among diabetes patients Harvard T.H. Chan School of Public Health
- Metabolic blockbusters enter the bloodstream Medical Republic
- How do weight loss medications interact with the heart? WGN Radio 720
- GLP-1s and Immune Modulation: Exploring Anti-Inflammatory Potential Diabetes In Control
Emerging Role of Dual Glucagon-Like Peptide-1 (GLP-1)/Glucose-Dependent Insulinotropic Polypeptide (GIP) Receptor Agonists in Cardiovascular Prevention – Cureus
